That’s what he said in the latest interview (posted earlier, sorry for the terrible audio quality). He also said they have to do “large animal” testing before human clinical trials. There was a press release from the British venture capital firm Fortunis Capital, which is funding Stemson, saying that testing of the procedure is being conducted on pigs.
1 Like
Thx for update
1 Like
Yea thanks for the update Roger. Keep in mind that it will be available in Asia first and it could hit the market after one human study in Asia.
From Fortunis Capital -
-
Stemson are focussed on the path towards the first human trials. To achieve this goal the focus is on research and development, good infrastructure, strong regulatory environment, access to scientific talent and, of course, cost.
-
With its world class scientific talent and infrastructure, the UK is on the short list. Fortunis Capital believe they will find full support for this level of scientific innovation.
-
Ultimately there is an opportunity to develop the world’s first stem cell manufacturing line in the UK.
I saw that but there’s also the issue that they aren’t gearing up for human studies yet. Once they get to the point where they’re gearing up for human studies they will probably think long and hard about the fact that they can get to market a lot quicker in Asia than they can in Europe. This is important because the sooner they get to market the sooner they start making a profit. I think they will probably try to start human trials in Asia and the EU at about the same time. The USA will of course accept some EU approval processes but I don’t know if the USA will accept Asia’s rapid approval process.
Truth is, I’m beginning to think that a lot of the stuff we hear about Asia’s “rapid approval process” may be a myth. Japan passed a rapid approval process on paper but are they really putting it into practice? And what good is it if you have a rapid approval process if people can’t even get their foot in the door from the start and begin the clinical trials because the hurdles are too high.
I’m beginning to wonder exactly what happened to dr Tsuji in Japan. I think we only heard the tip of the iceberg of the story. Maybe he was telling his partner Organ Technologies the same stuff he was telling the public, which was that clinical trials were right around the corner. in 2018, he was putting out announcements saying “1 year to trials”. Then in 2019 when they were supposed to happen, they didn’t. We got no real explanation. We just noticed the time was going by and there were no trials. Then he finally admitted the delay, but again he said something to the effect of “1-2 years more to trials”. And it didn’t happen within 1 years or 2, obviously because we’re in 2021 now and there are no Tsuji trials.
Was dr Tsuji misleading everyone to create a buzz or something? What happened to the “rapid trials” in Japan? Did the Japanese government not think his procedure was ready for trials? Did Dr Tsuji say the same thing to Organ Technologies and RIKEN that he told the public? Does that mean he was misleading them?
Organ Technologies went bankrupt sometime 2020 to early 2021. Halrliciously said this was because of COVID, but didn’t offer any proof. How would COVID cause OT to go bankrupt?
Maybe what caused OT to go bankrupt was misleading assurances from Dr Tsuji, leading them to set aside and spend money that did not turn out to lead to clinical trials?
And if OT’s bankruptcy was because of bad information and wrong assurances from Dr Tsuji, that will come out in the financial record. Will that mean that Dr Tsuji’s reputation is tarnished and he’ll have a hard time finding a new partner to continue his work and get to trials?
This sounds very strange. Until theres actual proof from the japanese I’ll keep looking elsewhere. They said 2020 was the year well we’re halfway towards 2021 and nothing has come up to substantiate the japanese team’s claims.
Remember that during the period Tsuji had been talking about clinical trials coming soon (1-2 years) other scientists have been saying that they are hunting for a way to solve the mass-pass inductivity riddle. Tsuji has been saying that he has a way to do it but it does seem odd that he would be the only scientist to find the elusive solution. I’ve been thinking that he’s still working on that problem as other scientists have only recently found ways to solve the problem. This is one reason why I think Stemson may be the first to bring a cell-based cure to market. They have a way around the indctivity problem. Maybe nobody else, including Tsuji, has completely solved the problem yet. Anyway, this is what I’ve been thinking. I don’t really think Tsuji has 100% solved the inductivity problem yet.
Yes. Stemson is able to mass produce induced pluripotent stem cells, which they claim as their own discovery and have patented the process. In fact their business plan is to be the first stem cell “manufacturing line” in the UK.
Any results from stemson?